PuSH - Publication Server of Helmholtz Zentrum München

Modified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment.

Int. J. Hyperthermia 28, 33-42 (2012)
Publ. Version/Full Text Volltext DOI
Open Access Gold
Purpose: Adding hyperthermia to chemotherapy improved the clinical outcome of patients with high risk soft tissue sarcoma. Further improvement might be possible if combined with vaccination strategies. As no sarcoma-associated antigens are known, the ecto
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Hyperthermia ; Immune Monitoring ; Mva ; Sarcoma ; Tumour Vaccine; CYTOTOXIC T-CELLS; MELANOMA-ASSOCIATED ANTIGEN; AUTOLOGOUS TUMOR-CELLS; DENDRITIC CELLS; IN-VITRO; METASTATIC MELANOMA; HUMAN TYROSINASE; TRIAL; HYPERTHERMIA; VACCINATION
ISSN (print) / ISBN 0265-6736
e-ISSN 1464-5157
Quellenangaben Volume: 28, Issue: 1, Pages: 33-42 Article Number: , Supplement: ,
Publisher Informa Healthcare
Reviewing status Peer reviewed